Physician profile
Daniel Hurwit
NPI 1013302462
$61,017.48
in general payments reported to CMS, 2019-2025
8 companies · $276 in 2025
The $276 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $45K · 2021: $15K · 2022: $59.38 · 2023: $340 · 2024: $346 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $962.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $962.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $23,543.35 | 2020-2024 | |
| Lima USA, INC. | $17,500.00 | 2020 | |
| Smith+Nephew, INC. | $11,708.66 | 2020-2021 | |
| Peerless Surgical INC. | $5,486.35 | 2020-2021 | |
| United Orthopedics LLC | $1,200.00 | 2021 | |
| Stryker Corporation | $929.39 | 2020-2024 | Tornier Perform Anatomic Augmented Glenoid, Aequalis Perform+, Blueprint Patient Specific Instrumentation |
| Vericel Corporation | $403.65 | 2020-2025 | Maci |
| Catalyst Orthoscience | $246.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hurwit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.